Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ) | Finanzwire

Basculer en Français

10230	Companies
211154	Keywords
141073	Articles
111856	Press releases

Headlines Articles Press releases Eckert & Ziegler Strahlen- Und Medizintechnik AG

Home
Companies
Eckert & Ziegler Strahlen- Und Medizintechnik AG

BRIEF

published on 04/14/2026 at 10:02, 2 days 16 hours ago

Eckert & Ziegler Gains Attention with Buy Rating and Strong Upside Potential

Eckert & Ziegler BUY Rating Price Target Nuclear Medicine Upside Potential
PRESS RELEASE

published on 04/14/2026 at 09:57, 2 days 16 hours ago

Eckert & Ziegler: Metzler Initiates Coverage with a Buy Rating and a Price Target of € 21.00. Upside Potential: 41%
Metzler initiates coverage on Eckert & Ziegler SE with a Buy rating and a price target of €21.00, citing strong market position in nuclear medicine

BUY Rating Price Target Eckert & Ziegler SE Nuclear Medicine Metzler
BRIEF

published on 04/10/2026 at 10:05, 6 days 16 hours ago

Eckert & Ziegler Gains MDR Certification for Critical Eye Cancer Treatment

MDR Certification Brachytherapy Medical Device Regulation Eye Cancer Treatment Ru-106 Eye Applicators
PRESS RELEASE

published on 04/10/2026 at 10:00, 6 days 16 hours ago

Eckert & Ziegler Secures Patient Access to Critical Eye Cancer Treatment with MDR Certification for Ru-106 Eye Applicators
Eckert & Ziegler obtains MDR certification for Ru-106 Eye Applicators, securing patient access to critical eye cancer treatment. Milestone ensures long-term availability in EU

Eckert & Ziegler MDR Certification Patient Access Eye Cancer Treatment Ru-106 Eye Applicators
BRIEF

published on 03/27/2026 at 09:06, 20 days 17 hours ago

Eckert & Ziegler SE: Strong Underlying Momentum and Growth Prospects

Buy Recommendation Eckert & Ziegler Radiopharma Growth Isotope Sales Lu-177 & Ac-225
PRESS RELEASE

published on 03/27/2026 at 09:01, 20 days 17 hours ago

Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
NuWays AG's research report upgrades Eckert & Ziegler SE classification. Detailed analysis reveals stronger revenue and earnings growth prospects for 2026, backed by positive radiopharma developments and strategic flexibility

NuWays AG Financial Analysis Earnings Growth Eckert & Ziegler SE Radiopharma
BRIEF

published on 03/26/2026 at 07:50, 21 days 18 hours ago

Eckert & Ziegler Reports Robust 2025 Financial Performance and Optimistic 2026 Forecast

Financial Performance Medical Segment Isotope Products 2025 Results 2026 Forecast
PRESS RELEASE

published on 03/26/2026 at 07:45, 21 days 18 hours ago

Eckert & Ziegler: Strong FY 2025 with Positive Outlook
Eckert & Ziegler SE achieved strong performance in FY 2025 with sales of €312.0 million and plans for approx. €320 million sales in 2026, alongside an adjusted EBIT of approx. €80 million

Sales Growth Forecast Earnings Increase Eckert & Ziegler SE FY 2025
BRIEF

published on 03/06/2026 at 10:41, 1 month 10 days ago

Eckert & Ziegler Proposes €0.22 Dividend per Share for 2025

Annual General Meeting Investor Relations Eckert & Ziegler Dividend Proposal Financial Year 2025
PRESS RELEASE

published on 03/06/2026 at 10:36, 1 month 10 days ago

EQS-Adhoc: Eckert & Ziegler Plans Dividend of € 0.22 per Share for 2025
Eckert & Ziegler SE plans dividend of €0.22 per share for 2025, subject to AGM approval. Detailed financial statements to be released on March 26, 2026

Shareholders Annual Financial Statements Dividend Eckert & Ziegler SE 2025 Financial Year

Accesswire

Published on 04/17/2026 at 02:00, 11 minutes ago

UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 2 hours 39 minutes ago

Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 4 hours 41 minutes ago

Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 15:55, 10 hours 16 minutes ago

TripSitter Announces Director Resignation
Published on 04/16/2026 at 15:20, 10 hours 51 minutes ago

Datavault AI Goes Live with First Edge GPU Sites in New York and Philadelphia; $1.44B-$1.92B Quantum-Ready Fleet to Reach 100+ U.S. Cities by End of 2026

View all ACCESSWIRE

EQS Group

Published on 04/16/2026 at 23:40, 2 hours 31 minutes ago

Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 4 hours 34 minutes ago

Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 5 hours 11 minutes ago

Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 5 hours 36 minutes ago

EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 6 hours 54 minutes ago

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year

Les Echos

Published on 04/16/2026 at 18:02, 8 hours 9 minutes ago

Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 18:00, 8 hours 11 minutes ago

ICADE – PR – Q1 2026 TRADING UPDATE
Published on 04/16/2026 at 17:55, 8 hours 16 minutes ago

Publication of 2026 1st quarter turnover
Published on 04/16/2026 at 17:54, 8 hours 17 minutes ago

Aéroports de Paris S.A - March 2026 traffic figures
Published on 04/16/2026 at 17:45, 8 hours 26 minutes ago

VOGO : 2025 full-year results.

View all LES ECHOS COMFI WIRE